Sunday, August 16, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
InjectablesHugel Posts Record H1 on Toxin Surge—Overseas Growth AcceleratestodayMarketHugel Posts Record H1 Revenue on Overseas Toxin Surge3 days agoDevices & TechApyx: GLP-1 Boom Is Fueling Renuvion DemandtodayMarketMedytox Q2 Sales Up 11%, Operating Profit Down 25%3 days agoInjectablesGalderma Wins EU Nod for Restylane ShaypeyesterdayBusiness & M&AEstablishment Labs Raises 2026 Revenue Guidance2 days agoDevices & TechMerz Ultherapy PRIME Clears FDA for Knee Skin LaxityyesterdayBusiness & M&ABeauty Health Q2 Earnings: Device Demand Steady2 days agoInjectablesHugel Debuts Thechaum Signature with Reduced CrosslinkeryesterdayDevices & TechAlma Launches TitaniumLift™ Multi-Depth RF Protocol2 days agoInjectablesGLP-1 Boom Exposed Filler Limitations—Here's WhyyesterdayInjectablesGalderma Chief: Start GLP-1 Patients on Skin Care First2 days ago
Markets & Filings

Antitrust Action

DOJ or FTC challenges to mergers or market power that can block deals or force breakups.

Also known as: DOJ/FTC Enforcement, Merger Challenge

What it is
Antitrust actions are enforcement moves by the Department of Justice or Federal Trade Commission against mergers or conduct that harm competition. They can sue to block deals, demand divestitures, or seek behavioral remedies. Courts ultimately decide contested cases.
What it does
A challenge injects deal-break risk, widening merger arbitrage spreads and pressuring the target's stock toward its standalone value. Conduct cases can threaten a dominant firm's business model. Investors handicap litigation odds and remedy scenarios.
The evidence
Announced government suits to block large mergers have widened arbitrage spreads and knocked target shares below deal price.
Best for
Announced merger targets and acquirers; dominant platform names.
Pairs well with
consent-decree, 8-k, event-driven
Use cautiously with
Governments lose cases too; assuming every challenge kills a deal can leave you on the wrong side of a court win.
Cautions
Litigation timelines are long and outcomes uncertain, so arbitrage carries real gap risk.
General information, not medical advice. Ingredient effects vary by formulation, concentration, and skin. Patch-test new actives and consult a qualified provider before starting prescription ingredients.

More markets & filings

Know what's coming before your patients ask for it.

New actives, device launches, and the FDA calls that change what you can offer — distilled into a two-minute brief, twice a week. Inside MedSpa Pro.

Go Pro · $20/mo
Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
The twice-a-week intelligence brief Go Pro · $20/mo →